SGLT2 INHIBITORS ASSOCIATE WITH OVERACTIVE BLADDER SYMPTOMS

被引：0
|
作者：
Mershon, J. Patrick
Weatherly, Taylor
Gill, Erin
Asif, Hafsa
Denis-Diaz, Dairon
Moore, Courtenay
Crescenze, Iryna
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
10.1097/01.JU.0001008772.30001.48.04
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD12-04
引用
收藏
页码：E257 / E257
页数：1
相关论文
共 50 条
  • [1] SGLT2 inhibitors for diabetes: turning symptoms into therapy
    Diamant, Michaela
    Morsink, Linde M.
    LANCET, 2013, 382 (9896): : 917 - 918
  • [2] SGLT2 INHIBITORS
    Brito, M.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E162 - E162
  • [3] SGLT2 inhibitors
    Dardi, I.
    Kouvatsos, T.
    Jabbour, S. A.
    BIOCHEMICAL PHARMACOLOGY, 2016, 101 : 27 - 39
  • [4] SGLT2 inhibitors
    Steyn, Lynda
    SA PHARMACEUTICAL JOURNAL, 2018, 85 (01) : 72 - 75
  • [5] SGLT2 Inhibitors and the Risk of Early Bladder Cancer Events
    Abrahami, Devin
    Tesfaye, Helen
    Yin, Hui
    Yu, Oriana Hoi Yun
    Platt, Robert W.
    Schneeweiss, Sebastian
    Patorno, Elisabetta
    Azoulay, Laurent
    DIABETES, 2022, 71
  • [6] Ketoacidosis with SGLT2 Inhibitors
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1471): : 94 - 94
  • [7] SGLT2 inhibitors and cardioprotection
    Chen, S.
    Wang, Q.
    Christodoulou, A.
    Mylonos, N.
    Bakker, D.
    Wakker, V.
    Hollmann, M. W.
    Weber, N. C.
    Coronel, R.
    Christoffels, V.
    Andreadou, I.
    Zuurbier, C. J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53
  • [8] SGLT2 inhibitors: are they safe?
    Filippas-Ntekouan, Sebastian
    Filippatos, Theodosios D.
    Elisaf, Moses S.
    POSTGRADUATE MEDICINE, 2018, 130 (01) : 72 - 82
  • [9] Development of SGLT1 and SGLT2 inhibitors
    Timo Rieg
    Volker Vallon
    Diabetologia, 2018, 61 : 2079 - 2086
  • [10] Development of SGLT1 and SGLT2 inhibitors
    Rieg, Timo
    Vallon, Volker
    DIABETOLOGIA, 2018, 61 (10) : 2079 - 2086
12345